Assignee
TOPADUR PHARMA AG
CH·7 granted patents·4 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
11 records- 0183US12351585B22-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Granted Jul 8, 2025·0 cites·20 claims
- 0276US11897890B22-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 13, 2024·0 cites·8 claims
- 0374US2024360136A1Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 0471US11905293B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 20, 2024·0 cites·21 claims
- 0571US2025320216A1Phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2025·Application pending·0 cites
- 0666US11242347B22-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2020·Granted Feb 8, 2022·0 cites·20 claims
- 0762US2025161309A1Topical compositions and uses therofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 0856US10570137B22-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2016·Granted Feb 25, 2020·0 cites·20 claims
- 0954US11155558B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1053US2025000869A1Topical compositions of 2-phenyl-3, 4-dihydropyrrolo [2, l-f] [1, 2, 4] triazinone derivatives and uses thereofTOPADUR PHARMA AG·Filed 2022·Application pending·0 cites
- 1140US12502393B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2019·Granted Dec 23, 2025·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →